Font Size: a A A
Keyword [pathological complete response]
Result: 1 - 20 | Page: 1 of 3
1. Relationship Between The Expression Of Biological Markers And The Responses Of Neoadjuvant Chemotherapy In Breast Cancer
2. Poly (ADP-ribose) Polymerase-1(PARP1)Expression In Breast Cancer Patients And Its Association With Polymorphisms In PARP1Promoter And3’untranslated Region And Chemotherapy Sensitivity
3. Predictors Of Pathological Complete Response And Changes In The Immunohistochemical Biomarkers Status After Neoadjuvant Chemotherapy For Breast Cancer
4. Advanced Ultrastructural Changes After Neoadjuvant Chemotherapy For Gastric Carcinoma And Spleen And Nourishing The Stomach The Prevention And Treatment Of Postoperative Adverse Reaction Of Chemotherapy
5. The Assessment Of Efficacy And Factors Related With Pathological Complete Response Of Neoadjuvant Chemotherapy In Breast Cancer
6. The Study Of Effect And Prognosis Of Neoadjuvant Chemotherapy For Triple-negative Breast Cancer
7. Predictors Of Pathological Complete Response And Efficacy After Neoadjuvant Chemotherapy For Breast Cancer In Young Women
8. The Study Of The Changes Of ER?PR?HER-2?Ki-67?p53 In Luminal Type Breast Cancer And The Long-term Efficacy
9. The Clinical Research Of Locally Advanced Gastric Cancer After Neoadjuvant Therapy And Liquid Biopsy In Gastric Cancer
10. Ki-67 Is A Predictive Marker For A Pathological Complete Response To Neoadjuvant Chemotherapy In Breast Cancer:a Meta-analysis
11. MR Predictors Of Pathological Complete Response To Neoadjuvant Chemoradiotherapy In Locally Advanced Rectal Caner
12. Value Of Apparent Diffusion Coefficient In Assessing The Response To Preoperative Chemoradiotherapy With Simultaneous Integrated Boost For Locally Advanced Rectal Cancer
13. Analysis Of Related Factors Of Pathological Complete Response After Neoadjuvant Therapy For Locally Advanced Rectal Cancer
14. Clinical Efficacy Evaluation Of Neoadjuvant Hormonal Therapy Followed By Radical Prostatectomy
15. A Clinical Study On Selective Elimination Of Breast And Axillary Surgery After Neoadjuvant Chemotherapy For Breast Cancer
16. Elastography-Assisted Evaluation Of The Clinical Application Of Complete Pathological Remission After Neoadjuvant Chemotherapy In Breast Cancer
17. Therapeutic Evaluation Of HER2-positive Breast Cancer With Neoadjuvant Chemotherapy Combined With Targeted Therapy
18. Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed By Docetaxel As Neoadjuvant Chemotherapy In Primary Breast Cancer:Results Of The Study
19. Efficacy Evaluation Of Neoadjuvant Chemotherapy For TEC Regimen In HER-2 Negative Breast Cancer
20. Effect Of Postoperative Chemotherapy On The Prognosis Of Patients With Stage ?A-?B HER2-negative Breast Cancer Without PCR After Neoadjuvant Chemotherapy
  <<First  <Prev  Next>  Last>>  Jump to